Evaluation of the Bio-Rad VARIANT™ II HbA2/HbA1C Dual Program for measurement of hemoglobin concentrations and detection of variants

被引:8
|
作者
Riou, J
Godart, C
Mathis, M
Hurtrel, D
Wajcman, H
Préhu, C
Bardakdjian, J
机构
[1] Hop Henri Mondor, Serv Biochem Genet, F-94010 Creteil, France
[2] Hop Henri Mondor, INSERM, U468, F-94010 Creteil, France
关键词
hemoglobin A(2); hemoglobin F; sickle cell disease; thalassemia;
D O I
10.1515/CCLM.2005.040
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
In this work data obtained on the VARIANT(TM) II hemoglobin analyzer using the Dual Kit elution system were compared to those obtained with the beta-Thalassemia Short Program. Since many laboratories still use an earlier model of the hemoglobin analyzer, the Variant(TM) 1, these data were also compared to those obtained with the latter instrument. Our study is divided into two parts. The first is an evaluation of the precision of the VARIANT(TM) II for determining the levels of hemoglobin (Hb)A(2) and Hb F. This was carried out for normal subjects, thalassemic patients and patients with HbS. The second part concerns the potential of this instrument in the presumptive identification of Hb variants.
引用
收藏
页码:237 / 243
页数:7
相关论文
共 50 条
  • [41] Prevalence of Hemoglobin variants in T2DM through HbA1c assessment
    Gupta, S.
    Baig, A.
    Gupta, S.
    Gupta, S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
  • [42] Preliminary comparative study of HBA1c measurement by IEX-HPLC Bio-Rad in dried blood spot vs. whole venous blood
    Hadami, Khaoula
    Bennai, Redouane Mammar
    Touyar, Nora
    Amar, Lahcen
    Harisoa, Yasminah Josephine
    Kabbaj, Hakima
    Benouda, Amina
    Belefquih, Bouchra
    ANNALES DE BIOLOGIE CLINIQUE, 2025, 83 (-1) : 61 - 71
  • [43] Measurement of glycated hemoglobin (HbA1c) with an automated POCT instrument in comparison with HPLC and automated immunochemistry method:: evaluation of the influence of hemoglobin variants
    Haliassos, A
    Drakopoulos, I
    Katritsis, D
    Chiotinis, N
    Korovesis, S
    Makris, K
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2006, 44 (02) : 223 - 227
  • [44] A diabetic patient with hemoglobin variant Hb Mito diagnosed from a change in HbA1c measurement method
    Higa M.
    Yoshifuji A.
    Doi A.
    Yoshida E.
    Yamashita K.
    Ichijo T.
    Ouchi H.
    Miyazaki A.
    Hirose T.
    Diabetology International, 2013, 4 (4) : 257 - 260
  • [45] Why understanding hemoglobin glycated measurement can be important: Santa Juana hemoglobin variant and falsely elevated HbA1c
    Lorand, Juan
    Boutsen, Laure
    Gueulette, Emmanuelle
    Maisin, Diane
    Closset, Melanie
    Mouraux, Thierry
    Beckers, Dominique
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 182 - 182
  • [46] Potential of MALDI-TOF mass spectrometry to overcome the interference of hemoglobin variants on HbA1c measurement
    Xu, Anping
    Xie, Weijie
    Wang, Yajun
    Ji, Ling
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2021, 59 (01) : 233 - 239
  • [47] Effect of hemoglobin, triglyceride, and urea in different concentrations on compatibility between methods used in HbA1c measurement
    Muhtaroglu, Sabahattin
    Barlak-Keti, Didem
    Saracoglu, Hatice
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2022, 47 (06): : 727 - 734
  • [48] Lipemia impact on HBA1C measurements in patients with and without hemoglobin variant: a rational laboratory use evaluation
    Demircin, Esra Yildirim
    Tutar, Sezen
    Sezer, Sevilay
    Akbiyik, Filiz
    Yilmaz, Gulsen
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2023, 83 (03): : 194 - 199
  • [49] Evaluation of hemoglobin J-Baltimore interference on HbA1c measurement using capillary electrophoresis
    Kittanakom, Saranya
    Halchuk, Linda M.
    McFarland, Andrew
    Macri, Joseph
    CLINICAL BIOCHEMISTRY, 2014, 47 (12) : 1152 - 1152
  • [50] Evaluation of glycated hemoglobin (HbA1C) as a predictor of dyslipidemia in type 2 diabetic patients
    Suhail, Nida
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2022, 13 (08): : 919 - 922